$Senseonics (SENS.US)$
I saw the news that diabetes can be cured now. does that mean, this stock ate doomed

$Pfizer (PFE.US)$ Following the prediction and strategy on February 2, in the subsequent market progress, the price did not hit the level of 26.2+, but started to rebound at 26.52! However, this one percent error is clearly not luck, but a mistake! Looking back at the 30-minute chart on 12/15/2023, 26.58 was the upper limit of the central range on the 30-minute chart from 12/13 to 12/15, while Murphy actually took 26.23 in actual trading, which is the axis of that range! The trend must be perfect! It is inevitable that there will be the first rebound on the 30-minute level beyond the current upper limit of the range, and then determine in the subsequent trend whether it will extend upwards or consolidate downwards! The upper limit of the consolidating range downwards then serves as a secondary replenishment point, while the axis at 26.23 is the optimal intraday trading point and even a position for adding to positions in swing trading; this depends on individual style and strategy to choose between day trading or swing trading! Missing 26.52 is, of course, not waiting around, but acting with the trend. The level of 27.50 is the axis of the daily chart, and 28.02 is the highest point of the rebound from 26.52, thus establishing the selling range of 27.50 to 28.02! Within this range, Murphy first executed a trade at 27.53, of course, this position was not very precise, overslept and luckily was awakened by a call from a buddy to place a trade with groggy eyes, because without monitoring, couldn't hit the intraday high point, so immediately placed an order at 27.20 for replenishment hoping to make back the difference of not selling near the high point with a low point replenishment trade within the day, but on February 6th, even that day...

$Senseonics (SENS.US)$
anyone knows what date and time SENS announce yheir Q4?

$Pfizer (PFE.US)$ Weekly divergence construction shows a prototype, but the deceptive lines that keep diverging cannot be ruled out. After all, at least a daily trend reversal needs to be established! Recursively analyzing the daily structure, in order to build the weekly divergence, it is necessary to first establish a trend of rising to 31 and then retracing to 28.9 at the daily level. However, it is obvious that the buying and selling momentum between 28.3 and 28.9 at the 30-minute level is weakening! Therefore, the probability of directly attacking near 31 at the daily level to retest 28.9 is not high. Instead, it is necessary to retrace directly from the current range of 28.3 to 28.9 to 27.3 to 26.7 to construct a perfect trend before choosing an upward, downward, or sideways trend! If choosing a downward trend, then sell part of the range from 28.3 to 28.6, and place an order to buy back at 27.3 to 26.7; this expected trading strategy remains unchanged! If the decline is not over, it will continue to retest from the weak rebound at 25.7 mentioned earlier to 27.15, and then continue to drop to establish the lower limit at 24.9; and if the 30-minute level once again volume surges to create a daily trend from 31 to 28.9, then a solid move at 31 should be followed by another move, and a retest of 28.9 will have a higher probability of occurring! This may be the construction of a new trend center, with weekly bottom divergence and the emergence of large bullish candles with high volume! Therefore, in terms of trading strategy, it is important to repurchase the chips flying from 28.3 to 28.6 within the new central range! The above is just a personal trading note and does not constitute investment advice or opinions! Trading is at your own discretion! Profit and loss are your own responsibility!

$Pfizer (PFE.US)$
I have waited for this moment a long time.  PFE has finally dropped to its 15-year support line.  In a normal environment, it takes a catastrophe for a stock to break this support line.  Even 2020 PFE didn't break it.  PFE is an extremely strong company,  been around for over 100 years, low debt, high cash flow and the best it pays a divided!   So if it pays 5% dividend and it drops 5% from Here I breakeven.
add -  I can't include this here, but check out th...

$Pfizer (PFE.US)$
PFE earnings before open tomorrow.  If earnings or forecast is a major negative surprise, PFE will head down to around $25. If not, PFE will recover very quickly.  I think investors are more focused on the forecast to see how bad the Covid vaccine impacts. 
$SPDR S&P 500 ETF (SPY.US)$

$Pfizer (PFE.US)$
There is more than 20Millions cancer patients and there is more without diagnosed. Annual cost per patient around $42,000 USD. Will a pharmaceutical giants lived off by Covid-19? No, they live off their innovations and biotechnologies. Cancer treatment market are around 700 Billions and keep increasing due to chemical contamination and food safety concerns. right now Pfizer is at the  lowest since 2016. Dimond hands remains and weaks ...